|
1. Branger C, Zamfir O, Geoffroy S, Laurans G, Arlet G, Thien HV, et al. Genetic background of Escherichia coli and extended-spectrum beta-lactamase type. Emerg Infect Dis. 2005 Jan; 11(1): 54-61. 2. Cantón R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, et al. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect. 2008 Jan; 14 (Suppl 1): 144-53. 3. Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother. 2004 Jan; 48(1): 1-14. 4. Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L. Prevalence and molecular epidemiology of CTX-M extended-spectrum ß-lactamase-producing Escherichia coli. and Klebsiella pneumoniae in russian hospitals. Antimicrob Agents Chemother. 2003 Dec; 47(12): 3724-32. doi:10.1128/AAC.47.12.3724-3732.2003 5. Duttaroy B, Mehta S. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli. Indian J Pathol Microbiol. 2005 Jan; 48(1): 45-8. 6. Malini AB, Sageerabanoo S, Kowsalya R,Sarkar G. The occurrence of CTX-M3 type extended Spectrum Beta Lactamases among Escherichia Coli causing urinary tract infections in a Tertiary Care Hospital in Puducherry. J Clin Diagn Res. 2012; 6(7): 1203-6. 7. Liu G, Ling BD, Zeng Y, Lin L, Xie YE, Lei J. Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Enterobacter cloacae from a Teaching Hospital in China. Jpn J Infect Dis. 2008 Jul; 61(4): 286-9. 8. Cantón R, Coque TM. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol. 2006 Oct; 9(5): 466-75. 9. Mirzaee M, Pourmand MR, Chitsaz M, Mansouri S. Antibiotic resistance to third generation cephalosporins due to CTX-M-type extended-spectrum β-lactamases in clinical isolates of Escherichia coli. Iran J Public Health. 2009; 38(1): 10-17. 10. Khurana S, Taneja N, Sharma M. Extended spectrum beta-lactamase mediated resistance in urinary tract isolates of family Enterobacteriaceae. Indian J Med Res. 2002 Oct; 116: 145-9. 11. Taşli H, Bahar IH. Molecular characterization of TEM- and SHV-derived extended-spectrum beta-lactamases in hospital-based Enterobacteriaceae in Turkey. Jpn J Infect Dis. 2005 Jun; 58(3): 162-7. 12. Ryoo NH, Kim EC, Hong SG, Park YJ, Lee K, Bae IK, et al. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J Antimicrob Chemother. 2005 Oct; 56(4): 698-702. 13. Babaii Kochaksaraii M, Nasrolahi Omran A, Javid N, Shakeri F, Yazdi M, Ghaemi EA. [Extended spectrum beta lactamase producing E.coli isolated from Gorgan, North of Iran]. Medical Laboratory Journal. 2012; 6(1): 51-58. [Article in Persian]
|
